Biotech is our opening topic this morning as we deep dive into a double announcement from EQT. The firm is acquiring a Swedish biotech company as part of the launch of a new Healthcare Growth Strategy ...
BOSTON and STOCKHOLM, Jan. 28, 2026 (GLOBE NEWSWIRE) -- Mabtech, a global life science tools company specializing in advanced immunoassays, and Sai Life Sciences, a leading integrated Contract ...
Sai Life Sciences' Boston site designated as co-marketed U.S. execution hub for Mabtech's EYRA platform, bringing high-sensitivity multiplex immune profiling to biopharma and biotech clients across ...
EQT has announced the acquisition of Swedish biotech company Mabtech in what partner Isabel de Paoli told PE Hub Europe was a “perfect fit” for the private equity firm’s new Healthcare Growth Strategy ...
The MarketWatch News Department was not involved in the creation of this content. Sai Life Sciences' Boston site designated as co-marketed U.S. execution hub for Mabtech's EYRA platform, bringing high ...
Mabtech, a global life science tools company specializing in advanced immunoassays, and Sai Life Sciences, a leading integrated contract research, development, and manufacturing organization (CRDMO), ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results